Quantcast

Brain Cancer Global Clinical Trials Review, H1, 2014

April 17, 2014

LONDON, April 17, 2014 /PRNewswire/ — Reportbuyer.com has added a new market research report:

Brain Cancer Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/drug_discovery/brain_cancer_global_clinical_trials_review_h1_2014.html

Brain Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData’s clinical trial report, “Brain Cancer Global Clinical Trials Review, H1, 2014″ provides data on the Brain Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brain Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Brain Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Brain Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Brain Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Brain Cancer 25
Subjects Recruited Over a Period of Time 34
Clinical Trials by Sponsor Type 35
Prominent Sponsors 36
Top Companies Participating in Brain Cancer Therapeutics Clinical Trials 37
Prominent Drugs 38
Latest Clinical Trials News on Brain Cancer 39
Jan 07, 2014: e-Therapeutics provides update on ETS2101 phase I trial in brain cancer 39
Dec 16, 2013: Positive Phase 2 Results from Agenus’ Brain Cancer Vaccine Published in Neuro-Oncology 39
Nov 25, 2013: NewGen Therapeutics Reports Potent Anticancer Activity for Targeted Brain Cancer Drug, NT-113 40
Oct 21, 2013: Angiochem Initiates Phase 2 Clinical Study for Lead Drug Candidate, ANG1005, in Primary Brain Cancer 41
Jun 11, 2013: Critical Outcome Technologies Announces Positive Preclinical Results Of Cancer Drug Candidiate COTI-2 Against p53 Gene Mutations 41
Clinical Trial Profiles 43
Clinical Trial Overview of Top Companies 43
F. Hoffmann-La Roche Ltd. 43
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 43
GlaxoSmithKline plc 45
Clinical Trial Overview of GlaxoSmithKline plc 45
Novartis AG 47
Clinical Trial Overview of Novartis AG 47
Merck & Co., Inc. 48
Clinical Trial Overview of Merck & Co., Inc. 48
Pfizer Inc. 49
Clinical Trial Overview of Pfizer Inc. 49
Sanofi 50
Clinical Trial Overview of Sanofi 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
Bayer AG 52
Clinical Trial Overview of Bayer AG 52
Burzynski Research Institute, Inc. 53
Clinical Trial Overview of Burzynski Research Institute, Inc. 53
AngioChem Inc. 54
Clinical Trial Overview of AngioChem Inc. 54
Clinical Trial Overview of Top Institutes / Government 55
National Cancer Institute 55
Clinical Trial Overview of National Cancer Institute 55
The University of Texas M. D. Anderson Cancer Center 66
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 66
Memorial Sloan Kettering Cancer Center 68
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 68
Duke University 71
Clinical Trial Overview of Duke University 71
Children’s Oncology Group 73
Clinical Trial Overview of Children’s Oncology Group 73
European Organization for Research and Treatment of Cancer 75
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 75
Sidney Kimmel Comprehensive Cancer Center 77
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 77
Pediatric Brain Tumor Consortium 78
Clinical Trial Overview of Pediatric Brain Tumor Consortium 78
Stanford University 79
Clinical Trial Overview of Stanford University 79
Five Key Clinical Profiles 80
Appendix 119
Abbreviations 119
Definitions 119
Research Methodology 120
Secondary Research 120
About GlobalData 121
Contact Us 121
Disclaimer 121
Source 122

List of Tables

Brain Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Brain Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Brain Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Brain Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Brain Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Brain Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Brain Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Brain Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Brain Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Brain Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Brain Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Brain Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Brain Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Brain Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Brain Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Brain Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Brain Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Brain Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 34
Brain Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 35
Brain Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 36
Brain Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 37
Brain Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 38
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 43
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 45
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 47
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 48
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 49
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 50
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 51
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 52
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2014* 53
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AngioChem Inc., 2014* 54
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 55
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 66
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 68
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 71
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Children’s Oncology Group, 2014* 73
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 75
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014* 77
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pediatric Brain Tumor Consortium, 2014* 78
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 79

List of Figures

Brain Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Brain Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Brain Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Brain Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Brain Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Brain Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Brain Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Brain Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Brain Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Brain Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Brain Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Brain Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Brain Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Brain Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 34
Brain Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 35
Brain Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 36
Brain Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 37
Brain Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 38
GlobalData Methodology 120


Read the full report:
Brain Cancer Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/drug_discovery/brain_cancer_global_clinical_trials_review_h1_2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


Source: PR Newswire



comments powered by Disqus